Safety Study of Sargramostim in Treating Patients With Mild Cognitive Impairment Due to Alzheimer's Disease
Stopped Slow recruitment
Conditions
- Dementia Alzheimer's Type
Interventions
- DRUG: Sargramostim GZ402664
- DRUG: Placebo
- DRUG: Florbetapir F18
Sponsor
Sanofi
Collaborators